Category: UPS Press Release

Industry veteran to drive deeper global trade connections and sustainable growth opportunities for UPS customers in China

UPS appointed Bernard Jiang (蒋骞) as president of UPS China. With close to 20 years of experience in international supply chain and trade management, Bernard will oversee UPS’s business and operations in China. He will continue to help customers drive cross-border connectivity and create resilient supply chains.

“As the Chinese economy continues its recovery, it is a privilege to lead UPS’s business here,” said Jiang. “UPS has been helping businesses in China access global markets for over 30 years, driving digital transformation to enable Chinese businesses adjust to new demands, make the most of their supply chains and accelerate global growth. We have experienced long-term success in our development here, and will continue to provide tailored solutions for a diverse, rapidly evolving and dynamic local customer base.”

Jiang succeeds Michelle Ho, who was recently named UPS’s Asia Pacific region president.

Marken, UPS Healthcare’s clinical trial logistics unit, adds significant capacity to support increased demand for cell and gene therapies

Marken, the clinical trial logistics operation with UPS Healthcare, has expanded its global network to support increased demand for its clinical drug supply chain services, particularly for cell and gene clinical trials. Plans for the remainder of 2021 and 2022 will support accelerated demand for mRNA therapies, cell and gene therapies, early access and managed access programs. Expansion plans include new locations, expanded cold chain services and packaging solutions.

The Independent Pilots Association (UPS pilots) fully supports the “Safe Skies Act of 2021” introduced in the U.S. Senate by Sen. Amy Klobuchar (D-MN) and in the U.S. House of Representatives by Rep. Salud Carbajal (D-CA).

“Senator Klobuchar has been our long term legislative champion fighting to ensure that the FAA’s flight duty and rest requirements equally apply to all-cargo carriers,” said IPA President, Captain Robert Travis. “Her unwavering commitment will end the cargo carve out and bring Part 117 back in line with Congress’s original intent, one level of safety for U.S. aviation.”

UPS Cold Chain Solutions brings full suite of end-to-end cold chain capabilities to customers worldwide

UPS (NYSE: UPS) is expanding its specialty pharmaceutical offerings by establishing UPS Cold Chain Solutions, a comprehensive suite of cold chain technologies, best-in-class capabilities, and new and expanded global facilities providing complete, end-to-end temperature-controlled logistics.

“Our customers have been taking advantage of our cold chain capabilities for years, but the pandemic caused UPS to move even faster to enhance an integrated set of cold chain solutions to support the future of the pharmaceutical and medical device industry,” said Wes Wheeler, UPS Healthcare president. “UPS’s near-perfect, on-time delivery of the COVID-19 vaccine proves how effectively and efficiently our network handles biologically derived drugs, even at extreme temperatures.”

Chronic and life-threatening diseases, including cancers, respiratory, autoimmune and cardiovascular conditions, are the fastest growing disease categories in the world, creating a rapid acceleration in the development of biologically derived, temperature-controlled drugs and therapies. According to the Biopharma Cold Chain Sourcebook, cold chain trends show 48 percent growth between 2018 and 2024 for drugs that require at least 2 to 8 degrees Celsius storage and shipping. Additionally, the overall market for cold chain services (packaging, transportation and data services) is expected to significantly accelerate growth over the next three years, growing by 24 percent by 2024, after posting a 10 percent increase from 2019 to 2020.